SCHEMBL10064196

SCHEMBL10064196

NCCN1CC[C@H](CO)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 1/20 0.43
ARG2 P78540 1/20 0.43
CARM1 Q86X55 2/20 0.43
PRMT6 Q96LA8 2/20 0.43
PRMT3 O60678 1/20 0.43
PRMT1 Q99873 1/20 0.43
PRMT8 Q9NR22 1/20 0.43
ALOX15 P16050 1/20 0.42
GNAI3 P08754 2/20 0.41
GNAO1 P09471 2/20 0.41
GNAI1 P63096 2/20 0.41
NCF1 P14598 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
CYP2D6 P10635 1/20 0.34
HRH3 Q9Y5N1 3/20 0.33
LTA4H P09960 2/20 0.32
CHRM3 P20309 1/20 0.31
ACHE P22303 1/20 0.31
BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25344529 1.00 ARG1 (0.43) ARG1ARG2CARM1PRMT6PRMT3
SCHEMBL10064775 1.00 ARG1 (0.43) ARG1ARG2CARM1PRMT6PRMT3
SCHEMBL10064309 0.88 CYP2D6 (0.45) ARG1ARG2CARM1PRMT6PRMT3
SCHEMBL3897612 0.88 CYP2D6 (0.45) ARG1ARG2CARM1PRMT6PRMT3
SCHEMBL6783180 0.87 ALOX15 (0.52) ARG1ARG2CARM1PRMT6PRMT3
SCHEMBL3429474 0.83 ARG1 (0.42) ARG1ARG2CARM1PRMT6HTR1D
SCHEMBL3427083 0.79 ARG1 (0.43) ARG1ARG2GNAO1HTR1DHTR1B
SCHEMBL2386729 0.79 ARG1 (0.40) ARG1ARG2CARM1PRMT6HTR1D
SCHEMBL3429374 0.79 ARG1 (0.43) ARG1ARG2GNAO1HTR1DHTR1B
SCHEMBL13560174 0.79 GBA1 (0.43) ARG1ARG2GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120083489-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS GLAXOSMITHKLINE LLC 2012-04-05 US disclosed
WO-2010141539-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083489-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS MCHR1, MCHR2, MC1R ARG1 2623/4885ARG2 2624/4885CARM1 4406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.